SCHEMBL10065171

SCHEMBL10065171

CCC(C)c1ccc2c(c1)c1ccccc1n2-c1ccc(-c2nc3ccccc3o2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B10 Q99714 5/20 0.42
▸ KDM4E B2RXH2 4/20 0.42
▸ ALDH1A1 P00352 4/20 0.42
▸ HPGD P15428 4/20 0.42
▸ NPC1 O15118 6/20 0.42
▸ RAB9A P51151 4/20 0.42
▸ TP53 P04637 2/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ PTPN2 P17706 3/20 0.40
▸ PTPN1 P18031 3/20 0.40
▸ PTPN5 P54829 3/20 0.40
▸ MEN1 O00255 3/20 0.40
▸ KMT2A Q03164 3/20 0.40
▸ ATM Q13315 1/20 0.40
▸ MAPT P10636 3/20 0.38
▸ TSHR P16473 2/20 0.38
▸ HCRTR1 O43613 1/20 0.38
▸ USP2 O75604 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ CASP3 P42574 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10065278 0.99 HSD17B10 (0.42) HSD17B10KDM4EALDH1A1HPGDNPC1
SCHEMBL10065140 0.97 NPC1 (0.44) HSD17B10KDM4EALDH1A1HPGDNPC1
SCHEMBL10065255 0.96 NPC1 (0.43) HSD17B10KDM4EALDH1A1HPGDNPC1
SCHEMBL10065414 0.94 NPC1 (0.40) HSD17B10KDM4EALDH1A1HPGDNPC1
SCHEMBL13426426 0.92 NPC1 (0.45) HSD17B10KDM4EALDH1A1HPGDNPC1
SCHEMBL10065376 0.91 HPGD (0.40) HSD17B10KDM4EALDH1A1HPGDNPC1
SCHEMBL10065102 0.91 KDM4E (0.51) HSD17B10KDM4EALDH1A1HPGDNPC1
SCHEMBL10065197 0.90 KDM4E (0.50) HSD17B10KDM4EALDH1A1HPGDNPC1
SCHEMBL10065175 0.90 NPC1 (0.49) HSD17B10KDM4EALDH1A1HPGDNPC1
SCHEMBL10065279 0.89 NPC1 (0.48) HSD17B10KDM4EALDH1A1HPGDNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8735597-B2 Benzoxazole derivative, and light-emitting element, light-emitting device, and electronic device using benzoxazole derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-05-27 — — US disclosed
US-8735597-B2 Benzoxazole derivative, and light-emitting element, light-emitting device, and electronic device using benzoxazole derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-05-27 — — US disclosed
US-20120104376-A1 Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Benzoxazole Derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-05-03 — — US disclosed
US-20120104376-A1 Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Benzoxazole Derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-05-03 — — US disclosed
US-8093399-B2 Benzoxazole derivative, and light-emitting element, light-emitting device, and electronic device using benzoxazole derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-01-10 — — US disclosed
US-8093399-B2 Benzoxazole derivative, and light-emitting element, light-emitting device, and electronic device using benzoxazole derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-01-10 — — US disclosed
US-20100060154-A1 Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Benzoxazole Derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2010-03-11 — — US disclosed
US-20100060154-A1 Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Benzoxazole Derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2010-03-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100060154-A1 Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Benzoxazole Derivative GABRA1, GABRA4, GABRA5 HSD17B10 1816/4885KDM4E 3212/4885ALDH1A1 165/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback